Interestingly, rActivin A treatment and Ad‐activin A infection of chondrocytes increased HIF‐2α expression and activity, whereas an AP‐1 inhibitor blocked HIF‐2α expression in our system (Figure S9c, Supporting Information). Here, EPAS1 is linked to infection.